KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.61.

  • Pfizer's FCF Payout Ratio fell 6547.5% to 0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16, marking a year-over-year increase of 3797.03%. This contributed to the annual value of 0.97 for FY2024, which is 4986.93% down from last year.
  • Per Pfizer's latest filing, its FCF Payout Ratio stood at 0.61 for Q3 2025, which was down 6547.5% from 2.04 recorded in Q2 2025.
  • Over the past 5 years, Pfizer's FCF Payout Ratio peaked at 31.55 during Q2 2023, and registered a low of 2.04 during Q2 2025.
  • Over the past 5 years, Pfizer's median FCF Payout Ratio value was 0.46 (recorded in 2021), while the average stood at 2.55.
  • Data for Pfizer's FCF Payout Ratio shows a peak YoY increase of 817344.51% (in 2023) and a maximum YoY decrease of 46097.67% (in 2023) over the last 5 years.
  • Pfizer's FCF Payout Ratio (Quarter) stood at 0.26 in 2021, then surged by 41.19% to 0.37 in 2022, then skyrocketed by 51.07% to 0.55 in 2023, then soared by 220.69% to 1.77 in 2024, then crashed by 65.47% to 0.61 in 2025.
  • Its last three reported values are 0.61 in Q3 2025, 2.04 for Q2 2025, and 1.38 during Q1 2025.